Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Cancer Treatment Centers of America appoints medical oncology chief
Cancer Treatment Centers of America at Eastern Regional Medical Center in Philadelphia announced the hiring of Arturo Loaiza-Bonilla, MD, as chief of medical oncology and medical director of research.
National cancer organizations unite to reduce health disparities
Four leading national cancer organizations have united in their mission to reduce the number of health disparities in the United States and to ensure all patients, regardless of social demographics and socioeconomic status, benefit from cancer research, according to a joint position statement published in Journal of Clinical Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
9 new insights on colon cancer risk, screening
This month, an abundance of new research contributing to better understanding of colorectal cancer risk and interventions to improve screening was presented in the journals and at scientific meetings.
AstraZeneca, Merck to collaborate on olaparib development
AstraZeneca and Merck entered a global strategic collaboration to develop and commercialize olaparib to treat multiple malignancies.
Patient navigator program at barbershops boosts colon cancer screening in black men
A community-based, preclinical patient navigator program that recruited black men at local barbershops doubled the rate of colorectal cancer screening in this high-risk population.
Eisai submits supplemental new drug application to FDA for Lenvima
Eisai submitted a supplemental new drug application to the FDA to seek approval for lenvatinib as a frontline therapy for patients with hepatocellular carcinoma.
NCI, Children’s Oncology Group collaborate on trial to evaluate targeted drugs for pediatric cancers
NCI and the Children’s Oncology Group today announced enrollment opened for a phase 2 study designed to evaluate targeted therapies in children and adolescents with solid tumors.
Occult HBV does not affect HCC resection outcomes
The presence of hepatitis B core antibody, or HBcAb, did not affect the outcomes of hepatic resection in patients with either hepatitis C-related or non-B, non-C hepatocellular carcinoma, according to results of a recent study. However, the data showed a possible link between occult hepatitis B infection and hepatocarcinogenesis in patients with non-B, non-C HCC.
Financial incentive increases colonoscopy screening
Adding a financial incentive of $100 to an offer of colonoscopy screening by email increased the screening rate by more than twofold in a randomized control trial.
Overweight, obese adolescents at greater risk for colorectal cancer
Being overweight or obese in adolescence appeared linked to a greater risk for subsequent colon cancers in men and women, according to study results published in Cancer.
-
Headline News
COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective
October 09, 20244 min read -
Headline News
Bariatric surgery cuts pancreatic cancer risk for adults with or without type 2 diabetes
October 09, 20242 min read -
Headline News
A vaginal ring could soon offer women 3 months of HIV protection
October 09, 20244 min read
-
Headline News
COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective
October 09, 20244 min read -
Headline News
Bariatric surgery cuts pancreatic cancer risk for adults with or without type 2 diabetes
October 09, 20242 min read -
Headline News
A vaginal ring could soon offer women 3 months of HIV protection
October 09, 20244 min read